Table 1. Comparison of the baseline anthropometric and biochemical characteristics between Group A, Group B, and Group C .
p-Value ≤0.05 is taken as significant; *p ≤ 0.05 (Group A vs. Group B); **p ≤ 0.05 (Group A vs. Group C); *p ≤ 0.05; †p ≤ 0.05 (Group B vs. Group C).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, glycated hemoglobin.
Group A: Patients with normal glucose tolerance.
Group B: Patients with impaired glucose tolerance.
Group C: Patients with type 2 diabetes.
Parameters | Group A | Group B | Group C |
Age (years) | 44.17 ± 12.86 | 45.79 ± 12.6 | 52.03 ± 9.88** |
BMI (kg/m2) | 26.21 ± 4.53 | 28 ± 5.51 | 27.8 ± 6.4 |
Waist circumference (cm) | 91.48 ± 12.79 | 92.7 ± 11.84 | 98.67 ± 14.35** |
Hip circumference (cm) | 67.76 ± 14.42 | 102.73 ± 18.21 | 105.63 ± 12.9** |
SBP (mmHg) | 120.9 ± 17.02 | 125.17 ± 17.65 | 131.87 ± 23.01** |
DBP (mmHg) | 81.17 ± 10.69 | 81.03 ± 9.39 | 85.53 ± 10.89 |
Fasting glucagon (pg/ml) | 39.24 ± 4.5 | 44.51 ± 8.25 | 49.02 ± 9.15 |
Fasting plasma glucose (mg/dl) | 87.83 ± 10.44 | 107.73 ± 10.85* | 202.97 ± 10.23** |
Two-hour plasma glucose (mg/dl) | 100.93 ± 21.46 | 145.97 ± 16.89* | 275.64 ± 13.32** |
Cholesterol (mg/dl) | 220.43 ± 14.17 | 236.43 ± 12.31 | 248.9 ± 9.74** |
Triglyceride (mg/dl) | 163.63 ± 9.21 | 203.1 ± 8.49* | 216.37 ±14.21** |
HDL (mg/dl) | 38.43 ± 10.49 | 36.97 ± 5.93 | 20.47 ± 6.28** |
LDL (mg/dl) | 115.53 ± 12.51 | 108.83 ± 6.19 | 111.07 ± 12.31** |
HbA1c (mg/dl) | 5.35 ± 0.56 | 5.52 ± 0.7† | 6.83 ± 1.82** |